Navigation Links
UMass Amherst biochemists developing tools to stop plague and other bacterial threats

AMHERST, Mass. Biochemist Alejandro Heuck at the University of Massachusetts Amherst recently received a five-year, $950,000 grant from the National Institutes of Health to map the molecular structure of a needle-like tool used by deadly bacteria to drill holes in mammalian cell walls.

Once a channel is open, bacteria that cause such diseases as bubonic plague (Yersinia pestis), dysentery (Shigella), food poisoning (Salmonella) and sepsis (Pseudomonas aeruginosa) pump proteins in to destroy the body's ability to fight infection, killing millions each year worldwide. The researchers hope this advance will help to identify new targets for developing new drugs and treatment avenues

The new studies will build on a breakthrough reported last year by graduate student Fabian Romano and Heuck (pronounced Hoik), who were able to characterize enough of the bacterial needle to build a model membrane system for further experiments. This will let them study how the molecular machine known as the Type III secretion system (T3S) pokes holes, or translocons, in cell walls of warm-blooded animals and humans to inject toxic proteins.

The T3S system is used by many pathogens, but the UMass Amherst team will study it in Pseudomonas aeuginosa because unlike many bacteria, this one has only one T3S system, allowing for experiments with fewer variables. This strain of Pseudomonas causes sepsis, which easily develops resistance to antibiotics. Also, because it can infect so many different organisms from roundworms to mice to people, Pseudomonas studies conducted in a glass culture dish can be readily tested in more complex organisms.

Heuck recalls that last year's breakthrough successfully opened the door to the current work by solving "a very difficult puzzle." He adds, "It took a lot of experiments to understand how these water-soluble, water-loving proteins in the T3S translocon system could suddenly transform themselves drastically, enough to be able attach to a lipid-dominated cell membrane to form this molecular syringe for attacking cells."

Now armed with that knowledge, Heuck and graduate student Yu-zhou Tang and others plan to use a special microscope to watch the organization of the channels at the single-molecule level. The will use multiple biochemical and biophysical methods, combined with fluorescent labeling of amino acids one at a time, to map two key protein translocators, Pseudomonas outer protein (Pop) B and D, and to figure out how they are assembled and how they form a translocon channel into a target cell.

With PopB and PopD, the biochemists can create a stable pore in model membrane for studying the relative quantities of different proteins, technically known as the stoichiometric arrangement, involved in T3S translocon assembly.

"No one has any idea right now how the PopB and PopD proteins get together, what it looks like when they fit together to form the channel. But it's important knowledge. If you want to know how to block these proteins from infecting the target cell, you must know how they are getting in and how they attack," Heuck says.

In five years, Heuck and colleagues hope to be able to offer hope to cystic fibrosis patients, many of whom lose their lives to Pseudomonas bacteria because at present, doctors run out of antibiotics that are effective against it. Further, many of these pathogens are listed as bioterrorism agents by the U.S. Centers for Disease Control and Prevention. It could become very important in the future to be able to mount an entirely new defense against their extremely effective methods of infecting populations with virulent bacterial diseases.

As he embarks on this major five-year study, Heuck says he is grateful to have received a bridge grant of $15,000 from UMass Amherst's Faculty Research/Healey Endowment Grant that allowed him to keep his lab open, actively gathering preliminary data to use in applying to NIH's National Institute of General Medical Sciences. "In these times when funding is really difficult, it gave us the chance to keep things going and to ultimately be competitive in getting the major support."


Contact: Janet Lathrop
University of Massachusetts at Amherst

Related biology news :

1. Alnylam and UMass Medical School announce Tuschl I patent upheld in European opposition proceedings
2. NIST/UMass study finds evidence nanoparticles may increase plant DNA damage
3. Chemical engineers at UMass Amherst find high-yield method of making xylene from biomass
4. UMass Amherst wildlife researcher photographs rare Sumatran rabbit
5. UMass Medical School scientist named 2012 Pew Latin-American Fellow in the Biomedical Sciences
6. UMass Medical School researchers discover a new role for RNAi
7. Family history of liver cancer increases risk of developing the disease
8. Research4Life greatly expands peer-reviewed research available to developing world
9. Medbox Developing a Patent Pending Wall-Mounted Biometric Kiosk for Storage of Sensitive Medicine Samples and Supplies for Doctors Offices.
10. Agricultural expert outlines path for developing nations to double food production, meet 2050 demand
11. VTT and GE Healthcare developing novel biomarkers to predict Alzheimers disease
Post Your Comments:
Related Image:
UMass Amherst biochemists developing tools to stop  plague and other bacterial threats
(Date:11/18/2015)... York , November 18, 2015 ... Research has published a new market report titled  Gesture ... Trends, and Forecast, 2015 - 2021. According to the report, ... 2014 and is anticipated to reach US$29.1 bn by ... 2021. North America dominated ...
(Date:11/17/2015)... , November 17, 2015 ... au 19 novembre  2015.  --> Paris ... --> DERMALOG, le leader de l,innovation biométrique, ... la fois passeports et empreintes sur la même surface ... les passeports et l,autre pour les empreintes digitales. Désormais, ...
(Date:11/17/2015)... SOUTH EASTON, Mass. , Nov. 17, 2015 /PRNewswire/ ... "Company"), a leader in the development and sale of ... to the worldwide life sciences industry, today announced it ... closing of its $5 million Private Placement (the "Offering"), ... Offering to $4,025,000.  One or more additional closings are ...
Breaking Biology News(10 mins):
(Date:11/27/2015)... November 27, 2015 ... popularity of companion diagnostics is one of ... market with pharmaceutical companies and diagnostic manufacturers ... tests. . --> ... report on global cancer biomarkers market spread ...
(Date:11/25/2015)... -- PharmAthene, Inc. (NYSE MKT: PIP) announced  today that its ... (Rights Plan) in an effort to preserve the value ... 382 of the Internal Revenue Code (Code). ... its NOLs could be substantially limited if the Company ... of the Code. In general, an ownership change occurs ...
(Date:11/25/2015)... Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... President and CEO of Neurocrine Biosciences, will be presenting ... New York . ... website approximately 5 minutes prior to the presentation to ... the presentation will be available on the website approximately ...
(Date:11/25/2015)... PORTLAND, Oregon , November 25, 2015 /PRNewswire/ ... Deep Market Research Report is a professional and ... Genomics industry.      (Logo: ... basic overview of the industry including definitions, classifications, ... analysis is provided for the international markets including ...
Breaking Biology Technology: